Plants are re-emerging as valuable platforms for pharmaceutical innovation with safe and scalable systems for the production of therapeutic compounds. This session will feature the role of medicinal plants as a source of alkaloids, flavonoids, and other bioactive molecules with pharmacological significance. Experts will present molecular farming strategies in which plants are genetically engineered to express vaccines, antibodies, and therapeutic proteins. Case studies of successful plant-based production of anti-cancer drugs, anti-malarials, and antiviral compounds will be shown. Metabolic engineering for improved secondary metabolite production will also be discussed. Emphasis will be on quality control, regulatory issues, and plant-derived pharmaceutical commercialization. We will discuss synthetic biology tools for pathway optimization and the discovery of novel compounds. Plant cell and tissue culture applications in pharmaceutical biotechnology will be emphasized. Students will come away with a complete picture of where plant biology and medicine converge to solve worldwide health issues.
Welcome to Plant Biology Conference 2026, where global researchers, academicians, and ecologists unite to share advancements in plant genetics, physiology, biotechnology, ecology, and sustainable agriculture and conservation practices.
